Acadian Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-79,735
| Closed | -$420K | – | 1732 |
|
|
2024
Q3 | $420K | Buy |
+79,735
| New | +$420K | ﹤0.01% | 1126 |
|
|
2023
Q3 | – | Sell |
-58,069
| Closed | -$132K | – | 1672 |
|
|
2023
Q2 | $132K | Sell |
58,069
-73,702
| -56% | -$168K | ﹤0.01% | 1352 |
|
|
2023
Q1 | $119K | Hold |
131,771
| – | – | ﹤0.01% | 1358 |
|
|
2022
Q4 | $111K | Sell |
131,771
-10,389
| -7% | -$8.75K | ﹤0.01% | 1411 |
|
|
2022
Q3 | $115K | Hold |
142,160
| – | – | ﹤0.01% | 1333 |
|
|
2022
Q2 | $141K | Buy |
142,160
+2,042
| +1% | +$2.03K | ﹤0.01% | 1280 |
|
|
2022
Q1 | $228K | Buy |
140,118
+58,952
| +73% | +$95.9K | ﹤0.01% | 1181 |
|
|
2021
Q4 | $194K | Buy |
81,166
+39,935
| +97% | +$95.5K | ﹤0.01% | 1245 |
|
|
2021
Q3 | $199K | Sell |
41,231
-9,748
| -19% | -$47K | ﹤0.01% | 1298 |
|
|
2021
Q2 | $136K | Buy |
50,979
+30,043
| +143% | +$80.1K | ﹤0.01% | 1552 |
|
|
2021
Q1 | $64K | Sell |
20,936
-71,566
| -77% | -$219K | ﹤0.01% | 1771 |
|
|
2020
Q4 | $330K | Sell |
92,502
-64,632
| -41% | -$231K | ﹤0.01% | 1365 |
|
|
2020
Q3 | $630K | Sell |
157,134
-24,621
| -14% | -$98.7K | ﹤0.01% | 1061 |
|
|
2020
Q2 | $494K | Buy |
+181,755
| New | +$494K | ﹤0.01% | 1196 |
|
|
2020
Q1 | – | Sell |
-79,233
| Closed | -$431K | – | 1802 |
|
|
2019
Q4 | $431K | Buy |
+79,233
| New | +$431K | ﹤0.01% | 1111 |
|
|
2019
Q3 | – | Sell |
-42,394
| Closed | -$159K | – | 1895 |
|
|
2019
Q2 | $159K | Hold |
42,394
| – | – | ﹤0.01% | 1279 |
|
|
2019
Q1 | $170K | Buy |
42,394
+8,165
| +24% | +$32.7K | ﹤0.01% | 1392 |
|
|
2018
Q4 | $125K | Hold |
34,229
| – | – | ﹤0.01% | 1223 |
|
|
2018
Q3 | $293K | Buy |
34,229
+12,735
| +59% | +$109K | ﹤0.01% | 999 |
|
|
2018
Q2 | $236K | Buy |
21,494
+12,119
| +129% | +$133K | ﹤0.01% | 1043 |
|
|
2018
Q1 | $108K | Buy |
+9,375
| New | +$108K | ﹤0.01% | 1191 |
|
|
2016
Q3 | – | Sell |
-159
| Closed | -$2K | – | 1437 |
|
|
2016
Q2 | $2K | Buy |
+159
| New | +$2K | ﹤0.01% | 1345 |
|